Nurix Therapeutics (NRIX) EPS (Basic) (2019 - 2026)
Nurix Therapeutics' (NRIX) quarterly EPS (Basic) came in at -$0.81 in Q2 2026, down 55.55% year-on-year from -$1.81 in Q2 2025, and down 0.88% on a QoQ basis from -$0.8 in Q1 2026.
Nurix Therapeutics (NRIX) EPS (Basic) (2019 - 2026) Analysis & Trends
Nurix Therapeutics (NRIX) has 8 years of EPS (Basic) data on file, last reported at -$0.81 in Q2 2026.
- On a quarterly basis, EPS (Basic) fell 55.55% year-over-year to -$0.81 in Q2 2026; TTM through May 2026 was -$3.08, a 24.61% decrease from a year earlier, with the FY2025 full-year figure at -$3.05, down 5.81% from the prior year.
- EPS (Basic) for Q2 2026 stood at -$0.81, down from -$0.8 in the prior quarter.
- Over the last five years, EPS (Basic) for NRIX reached as high as -$0.45 in Q2 2023 and fell as low as -$1.03 in Q3 2025.
- Historically, EPS (Basic) has averaged -$0.79 across 5 years, with a median of -$0.79 in 2023.
- Across the five-year window, EPS (Basic) tumbled 68.14% in 2022 and jumped 55.75% in 2023, its largest moves.
- Year by year, EPS (Basic) stood at -$0.96 in 2022, then rose by 19.66% to -$0.77 in 2023, then declined by 12.97% to -$0.87 in 2024, then dropped by 3.47% to -$0.9 in 2025, then increased by 10.7% to -$0.81 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.81 in Q2 2026, -$0.8 in Q1 2026, and -$0.9 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Nurix Therapeutics | 2.64 Bn | 2.19 Bn | - | -0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -0.81 |
| Feb 28, 2026 | -0.80 |
| Nov 30, 2025 | -0.90 |
| Aug 31, 2025 | -1.03 |
| May 31, 2025 | -0.52 |
| Feb 28, 2025 | -0.67 |
| Nov 30, 2024 | -0.87 |
| Aug 31, 2024 | -0.67 |
| May 31, 2024 | -0.71 |
| Feb 29, 2024 | -0.76 |
| Nov 30, 2023 | -0.77 |
| Aug 31, 2023 | -0.68 |
| May 31, 2023 | -0.45 |
| Feb 28, 2023 | -0.75 |
| Nov 30, 2022 | -0.96 |
| Aug 31, 2022 | -0.90 |
| May 31, 2022 | -1.01 |
| Feb 28, 2022 | -0.95 |
| Nov 30, 2021 | -0.88 |
| Aug 31, 2021 | -0.65 |